Laporan Laba Rugi (TTM)
Laporan Laba Rugi Melodiol Global Health Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 8 | 6 | 10 | 12 | 19 |
| Change (%) | -25.73 | 32.24 | 24.38 | 26.82 | 21.15 | 10.38 | 9.40 | 9.28 | -24.13 | 65.16 | 13.41 | 61.98 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 11 | 14 | 18 |
| Change (%) | 15.92 | 7.54 | 7.01 | -4.57 | -4.78 | -3.90 | -4.06 | 22.18 | -2.46 | 56.94 | 22.82 | 29.16 | |
| % of Revenue | 164.53 | 256.80 | 208.83 | 179.66 | 135.20 | 106.26 | 92.51 | 81.12 | 90.70 | 116.61 | 110.81 | 120.00 | 95.68 |
| Gross Operating Profit | -2 | -4 | -4 | -3 | -2 | -0 | 1 | 1 | 1 | -1 | -1 | -2 | 1 |
| Change (%) | 80.46 | -8.22 | -8.96 | -43.96 | -78.45 | -232.05 | 175.73 | -46.18 | -235.56 | 7.48 | 109.79 | -134.97 | |
| % of Revenue | -64.53 | -156.80 | -108.83 | -79.66 | -35.20 | -6.26 | 7.49 | 18.88 | 9.30 | -16.61 | -10.81 | -20.00 | 4.32 |
| SG&A | 10 | 10 | 15 | 21 | 24 | 27 | 23 | 18 | 18 | 13 | 18 | 19 | 14 |
| Change (%) | -1.23 | 60.07 | 37.53 | 13.60 | 11.97 | -15.76 | -18.70 | -4.91 | -27.44 | 40.58 | 7.03 | -27.60 | |
| % of Revenue | 293.94 | 390.93 | 473.20 | 523.22 | 468.68 | 433.18 | 330.62 | 245.68 | 213.79 | 204.47 | 174.04 | 164.24 | 73.41 |
| R&D | 0 | -0 | -0 | -0 | |||||||||
| Change (%) | 100.00 | -50.00 | |||||||||||
| % of Revenue | 6.63 | -3.92 | -6.31 | -2.49 | |||||||||
| OpEx | 16 | 17 | 23 | 29 | 32 | 35 | 30 | 25 | 27 | 22 | 33 | 37 | 34 |
| Change (%) | 2.99 | 36.60 | 26.80 | 9.30 | 8.51 | -13.11 | -15.08 | 5.43 | -18.97 | 50.18 | 13.59 | -8.16 | |
| % of Revenue | 491.96 | 682.20 | 704.72 | 718.41 | 619.19 | 554.62 | 436.61 | 338.88 | 326.97 | 349.21 | 317.54 | 318.03 | 180.32 |
| Operating Income | -13 | -14 | -20 | -25 | -27 | -28 | -23 | -18 | -19 | -16 | -22 | -25 | -15 |
| Change (%) | 10.32 | 37.35 | 27.20 | 6.47 | 6.08 | -18.27 | -22.36 | 3.83 | -16.70 | 44.17 | 13.67 | -40.33 | |
| % of Revenue | -391.96 | -582.20 | -604.72 | -618.41 | -519.19 | -454.62 | -336.61 | -238.88 | -226.97 | -249.21 | -217.54 | -218.03 | -80.32 |
| Interest Expense | -3 | -3 | -3 | -2 | -1 | -1 | -0 | -0 | -0 | -0 | -2 | -4 | -2 |
| Change (%) | 14.10 | -15.11 | -17.80 | -38.35 | -62.22 | -49.31 | -97.26 | 1,383.31 | -68.46 | 5,591.18 | 89.25 | -34.90 | |
| % of Revenue | -85.14 | -130.80 | -83.96 | -55.49 | -26.97 | -8.41 | -3.86 | -0.10 | -1.31 | -0.55 | -18.79 | -31.35 | -12.60 |
| Net Income | -29 | -31 | -32 | -32 | -31 | -30 | -24 | -18 | -25 | -33 | -43 | -54 | -52 |
| Change (%) | 7.78 | 2.53 | 2.47 | -3.57 | -3.70 | -19.77 | -24.65 | 40.29 | 28.72 | 32.28 | 24.40 | -2.78 | |
| % of Revenue | -860.43 | -1,248.68 | -968.18 | -797.64 | -606.52 | -482.12 | -350.41 | -241.35 | -309.84 | -525.69 | -421.02 | -461.80 | -277.18 |
Source: Capital IQ
